Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

Projects / Programmes source: ARIS

Farmacevtska kemija (Slovene)

Edit
Periods
January 1, 1999 - December 31, 2003
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
P390  Natural sciences and mathematics  Organic chemistry 
P310  Natural sciences and mathematics  Proteins, enzymology 
B190  Biomedical sciences  Clinical chemistry 
B191  Biomedical sciences  Plant biochemistry 
Evaluation (rules)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Researchers (28)
no. Code Name and surname Research area Role Period No. of publications
1.  21456  PhD Marko Anderluh  Pharmacy  Researcher  2001 - 2003  378 
2.  16328  PhD Matej Breznik  Pharmacy  Researcher  2001 - 2003  52 
3.  19062  PhD Jožko Cesar  Pharmacy  Researcher  2001 - 2003  69 
4.  19785  PhD Bojan Doljak  Pharmacy  Researcher  2001 - 2003  267 
5.  15284  PhD Stanislav Gobec  Pharmacy  Researcher  2001 - 2003  867 
6.  21459  PhD Nataša Karas Kuželički  Pharmacy  Researcher  2001 - 2003  179 
7.  01463  PhD Danijel Kikelj  Pharmacy  Head  2001 - 2003  576 
8.  21692  Irena Klančnik Mavec    Researcher  2001 - 2003  0 
9.  00839  PhD Aleš Krbavčič  Pharmacy  Researcher  2001 - 2003  348 
10.  17436  Marija Krbavčič    Researcher  2001 - 2003  1 
11.  03573  PhD Jana Lukač Bajalo  Microbiology and immunology  Researcher  2001 - 2003  302 
12.  12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher  2001 - 2003  722 
13.  18996  PhD Barbara Mlinar  Pharmacy  Researcher  2001 - 2003  48 
14.  18387  PhD Aleš Mlinarič  Pharmacy  Researcher  2001 - 2003  166 
15.  17437  Marjeta Mulej    Researcher  2001 - 2003  0 
16.  19061  PhD Aleš Obreza  Pharmacy  Researcher  2001 - 2003  341 
17.  10691  PhD Joško Osredkar  Human reproduction  Researcher  2001 - 2003  1,318 
18.  18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher  2001 - 2003  191 
19.  03070  PhD Slavko Pečar  Pharmacy  Researcher  2001 - 2003  415 
20.  19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher  2001 - 2003  422 
21.  19786  Majda Sirnik    Researcher  2001 - 2003  0 
22.  08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher  2001 - 2003  674 
23.  20372  PhD Petra Štefanič  Pharmacy  Researcher  2001 - 2003  33 
24.  21458  PhD Katja Štrancar  Pharmacy  Researcher  2001 - 2003  31 
25.  07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher  2001 - 2003  1,132 
26.  09635  PhD Andrej Umek  Pharmacy  Researcher  2001 - 2003  171 
27.  17438  Damijana Zalar    Researcher  2001 - 2003  0 
28.  18633  PhD Anamarija Zega  Pharmacy  Researcher  2001 - 2003  195 
Organisations (1)
no. Code Research organisation City Registration number No. of publications
1.  0787  University of Ljubljana, Faculty of Pharmacy  Ljubljana  1626973  17,911 
Abstract
Our research programme includes rational design, synthesis, characterization and biological testing of new active compounds of pure synthetic or natural origin, mainly peptidomimetics(e.g. thrombin inhibitors, fibrinogen receptor antagonists, analogs of N-acetylmuramyl-L-alanine-D-isoglutamine), which are designed as selective ligands of receptors and enzymes. The preferred target macromolecules are proteins with solved three-dimensional structure, e.g. human thrombin, which in connection with molecular modeling, efficient screening methods, X-ray analysis of protein-ligand complexes, molecular biology and combinatorial chemistry form a solid base for rational drug design. We are searching also for inhibitors ob serine and cysteine proteases in plans and fungi. A field of our research is also design and synthesis of novel spin labeled compounds, spin labeling of biologically important macromolecules and study of radical reactions of biologically active compounds. Our research interest is further devoted to the design and synthesis of new biocompatible materials with designed properties for new pharmaceutical formulations and to investigation of new diagnostic markers which will enable specific detection, diagnosis and monitoring of different pathological states.
Most important scientific results Final report
Most important socioeconomically and culturally relevant results Final report
Confirmation required
Views history
Favourite